SCHEMBL24609592

SCHEMBL24609592

c1ccc(-c2cc(-c3ccc4c(c3)nc(-c3ccccc3)c3c5ccc(-c6ccc7ccccc7c6)nc5ccc43)nc(-c3ccccc3)n2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A1 P04798 1/20 0.46
▸ CYP1B1 Q16678 1/20 0.46
▸ MEN1 O00255 6/20 0.40
▸ KMT2A Q03164 6/20 0.40
▸ ALDH1A1 P00352 6/20 0.40
▸ MAPT P10636 4/20 0.40
▸ HPGD P15428 4/20 0.40
▸ NTSR1 P30989 1/20 0.40
▸ CYP1A2 P05177 3/20 0.39
▸ KDM4E B2RXH2 5/20 0.39
▸ LMNA P02545 2/20 0.39
▸ GLA P06280 1/20 0.39
▸ TP53 P04637 2/20 0.38
▸ HSD17B10 Q99714 2/20 0.38
▸ CYP2C19 P33261 1/20 0.38
▸ HIF1A Q16665 1/20 0.38
▸ CTRC Q99895 1/20 0.38
▸ SMN1; SMN2 Q16637 2/20 0.36
▸ BTK Q06187 1/20 0.36
▸ MAOA P21397 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24609900 0.98 CYP1A1 (0.46) CYP1A1CYP1B1MEN1KMT2AALDH1A1
SCHEMBL24609630 0.95 CYP1A1 (0.46) CYP1A1CYP1B1MEN1KMT2AALDH1A1
SCHEMBL24609713 0.94 CYP1A1 (0.40) CYP1A1CYP1B1MEN1KMT2AALDH1A1
SCHEMBL24609632 0.94 CYP1A1 (0.47) CYP1A1CYP1B1MEN1KMT2AALDH1A1
SCHEMBL24609687 0.94 MEN1 (0.44) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL24609860 0.93 CYP1A1 (0.46) CYP1A1CYP1B1MEN1KMT2AALDH1A1
SCHEMBL24609789 0.93 MEN1 (0.37) CYP1A1CYP1B1MEN1KMT2AALDH1A1
SCHEMBL24609700 0.93 CYP1A1 (0.39) CYP1A1CYP1B1MEN1KMT2AALDH1A1
SCHEMBL24609786 0.93 MEN1 (0.43) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL24609664 0.92 CYP1A1 (0.47) CYP1A1CYP1B1MEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220213098-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME LT MATERIALS CO., LTD. (KR) 2022-07-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220213098-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME CRY1, CYP1A1, CYP1B1 CYP1A1 2/4885CYP1B1 3/4885MEN1 343/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback